NCT05580796View on ClinicalTrials.gov

KSH01-R02-101 Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

October 11, 2025

Study Completion Date

October 11, 2027

Conditions

Solid Tumor

Interventions

DRUG

KSH01 injection

TCR-T cell injection

Trial Locations (1)

100000

RECRUITING

Chinese People's Liberation Army (PLA) General Hospital, Beijing

All Listed Sponsors

lead

TCRx Therapeutics Co.Ltd

INDUSTRY